|
C2CD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.87140000349618E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.82859999983987E-07 |
| Normal-vs-Stage2 |
1.164710E-04 |
| Normal-vs-Stage3 |
7.71730002124826E-09 |
| Normal-vs-Stage4 |
1.54982999999165E-05 |
| Stage1-vs-Stage2 |
8.759600E-01 |
| Stage1-vs-Stage3 |
4.783600E-02 |
| Stage1-vs-Stage4 |
9.859400E-01 |
| Stage2-vs-Stage3 |
1.451800E-01 |
| Stage2-vs-Stage4 |
8.874400E-01 |
| Stage3-vs-Stage4 |
1.377770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.56379999744539E-08 |
| Normal-vs-AfricanAmerican |
6.05479999999936E-05 |
| Normal-vs-Asian |
2.577400E-01 |
| Caucasian-vs-AfricanAmerican |
8.635000E-01 |
| Caucasian-vs-Asian |
2.836600E-01 |
| AfricanAmerican-vs-Asian |
3.727800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.97599999988086E-08 |
| Normal-vs-Female |
6.38199999958289E-07 |
| Male-vs-Female |
4.636800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.118200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62130000003202E-06 |
| Normal-vs-Age(61-80Yrs) |
3.36480000528994E-08 |
| Normal-vs-Age(81-100Yrs) |
1.583850E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.903000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.179400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.895800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.376200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.090040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.371600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.252800E-01 |
| Normal-vs-Grade 2 |
4.60530000023773E-07 |
| Normal-vs-Grade 3 |
2.78799999753332E-08 |
| Normal-vs-Grade 4 |
1.18569999996154E-06 |
| Grade 1-vs-Grade 2 |
2.803800E-02 |
| Grade 1-vs-Grade 3 |
6.024800E-03 |
| Grade 1-vs-Grade 4 |
2.150100E-02 |
| Grade 2-vs-Grade 3 |
2.668600E-01 |
| Grade 2-vs-Grade 4 |
5.815800E-01 |
| Grade 3-vs-Grade 4 |
8.169000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.72849999979796E-07 |
| Normal-vs-ccB subtype |
6.47959999988679E-07 |
| ccA subtype-vs-ccB subtype |
7.529000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.56169999990341E-07 |
| Normal-vs-N1 |
7.117900E-02 |
| N0-vs-N1 |
3.693200E-01 |
|
|
